...University 's Lombardi Comprehensive Cancer Center. Pardoll invented the GVAX cancer vaccines initially developed by Somatix Therapy Corp....

...seen," said Masuda. Cell Genesys received the GVAX platform when it acquired Somatix Therapy Corp. in 1997. Somatix...

...not thinking beyond that," Valerio said. "In those days the leading gene therapy companies were Somatix...

...programs now consist entirely of the GVAX cancer vaccines it acquired through its purchase of Somatix Therapy Corp....
...III depend on data, but also portfolio management." CEGE has made its own portfolio decisions. Somatix...
...lung cancer vaccine. In addition, the combination of CEGE's gene therapy vectors with technology from Somatix...

...the core gene therapy area. Finally, CEGE was contemplating an acquisition in gene therapy - Somatix...
...the core gene therapy area. Finally, CEGE was contemplating an acquisition in gene therapy - Somatix...

...Park, Calif. Business: Drug discovery Hired: Lawrence Cohen as COO, formerly VP of R&D at Somatix Therapy Corp....

...Contag said. Contag shares the CEO position with David Carter, former president and CEO of Somatix Therapy Corp....

...Ph.D., as VP of product development; formerly VP of regulatory, quality and clinical affairs at Somatix Therapy Corp. WIR...

...Angus Macdonald began coverage with a "buy" and a $10 target. The recent acquisition of Somatix Therapy Corp....

...charge related to acquired in-process technology and restructuring. Cell Genesys Inc. (CEGE), Foster City, Calif. Somatix Therapy Corp....